PortalPublikationenLong-term assessment of Asenapine vs. Olanzapine in patients...

Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder.

Standard

Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder. / Schoemaker, J; Naber, Dieter; Vrijland, P; Panagides, J; Emsley, R.

in: PHARMACOPSYCHIATRY, Jahrgang 43, Nr. 4, 4, 2010, S. 138-146.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schoemaker, J, Naber, D, Vrijland, P, Panagides, J & Emsley, R 2010, 'Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder.', PHARMACOPSYCHIATRY, Jg. 43, Nr. 4, 4, S. 138-146. <http://www.ncbi.nlm.nih.gov/pubmed/20205074?dopt=Citation>

APA

Schoemaker, J., Naber, D., Vrijland, P., Panagides, J., & Emsley, R. (2010). Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder. PHARMACOPSYCHIATRY, 43(4), 138-146. [4]. http://www.ncbi.nlm.nih.gov/pubmed/20205074?dopt=Citation

Vancouver

Schoemaker J, Naber D, Vrijland P, Panagides J, Emsley R. Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder. PHARMACOPSYCHIATRY. 2010;43(4):138-146. 4.

Bibtex

@article{801c80e5df8949129aae030b26c66279,
title = "Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder.",
abstract = "We conducted a double-blind 1-year trial of asenapine in patients with schizophrenia or schizoaffective disorder.",
keywords = "Adult, Humans, Aged, Middle Aged, Aged, 80 and over, Psychiatric Status Rating Scales, Adolescent, Young Adult, Treatment Outcome, Longitudinal Studies, Double-Blind Method, Dose-Response Relationship, Drug, Benzodiazepines therapeutic use, Antipsychotic Agents therapeutic use, Schizophrenia drug therapy, Heterocyclic Compounds with 4 or More Rings therapeutic use, Psychotic Disorders drug therapy, Adult, Humans, Aged, Middle Aged, Aged, 80 and over, Psychiatric Status Rating Scales, Adolescent, Young Adult, Treatment Outcome, Longitudinal Studies, Double-Blind Method, Dose-Response Relationship, Drug, Benzodiazepines therapeutic use, Antipsychotic Agents therapeutic use, Schizophrenia drug therapy, Heterocyclic Compounds with 4 or More Rings therapeutic use, Psychotic Disorders drug therapy",
author = "J Schoemaker and Dieter Naber and P Vrijland and J Panagides and R Emsley",
year = "2010",
language = "Deutsch",
volume = "43",
pages = "138--146",
journal = "PHARMACOPSYCHIATRY",
issn = "0176-3679",
publisher = "Georg Thieme Verlag KG",
number = "4",

}

RIS

TY - JOUR

T1 - Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder.

AU - Schoemaker, J

AU - Naber, Dieter

AU - Vrijland, P

AU - Panagides, J

AU - Emsley, R

PY - 2010

Y1 - 2010

N2 - We conducted a double-blind 1-year trial of asenapine in patients with schizophrenia or schizoaffective disorder.

AB - We conducted a double-blind 1-year trial of asenapine in patients with schizophrenia or schizoaffective disorder.

KW - Adult

KW - Humans

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - Psychiatric Status Rating Scales

KW - Adolescent

KW - Young Adult

KW - Treatment Outcome

KW - Longitudinal Studies

KW - Double-Blind Method

KW - Dose-Response Relationship, Drug

KW - Benzodiazepines therapeutic use

KW - Antipsychotic Agents therapeutic use

KW - Schizophrenia drug therapy

KW - Heterocyclic Compounds with 4 or More Rings therapeutic use

KW - Psychotic Disorders drug therapy

KW - Adult

KW - Humans

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - Psychiatric Status Rating Scales

KW - Adolescent

KW - Young Adult

KW - Treatment Outcome

KW - Longitudinal Studies

KW - Double-Blind Method

KW - Dose-Response Relationship, Drug

KW - Benzodiazepines therapeutic use

KW - Antipsychotic Agents therapeutic use

KW - Schizophrenia drug therapy

KW - Heterocyclic Compounds with 4 or More Rings therapeutic use

KW - Psychotic Disorders drug therapy

M3 - SCORING: Zeitschriftenaufsatz

VL - 43

SP - 138

EP - 146

JO - PHARMACOPSYCHIATRY

JF - PHARMACOPSYCHIATRY

SN - 0176-3679

IS - 4

M1 - 4

ER -